XML 75 R60.htm IDEA: XBRL DOCUMENT v3.22.1
STOCKHOLDERS’ EQUITY - Narrative (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended
Jan. 19, 2022
$ / shares
shares
Feb. 28, 2022
shares
Mar. 31, 2022
USD ($)
vote
$ / shares
shares
Jan. 31, 2022
shares
Jan. 18, 2022
shares
Dec. 31, 2021
$ / shares
shares
Mar. 31, 2021
shares
Jan. 31, 2021
$ / shares
Mar. 31, 2020
$ / shares
shares
Class of Stock [Line Items]                  
Common stock, shares authorized (in shares)     10,000,000,000     10,000,000,000      
Common stock, par value (in dollars per share) | $ / shares $ 0.00001   $ 0.0001     $ 0.0001      
Voting rights per share | vote     1            
Warrants outstanding (in shares)     14,900,000            
Exercise price of warrants (in dollars per share) | $ / shares     $ 11.50            
Common stock, exchange ratio 1.6001528688                
SPAC vesting shares (in shares)         1,700,000        
Issuances of common stock- vendor settlement (in shares)     1,600,000            
Number of common shares available for grant, outstanding (in shares)     128,800,000            
Common shares purchased for award (in shares)     31,900,000            
Weighted average price of shares purchased (in shares) | $ / shares     $ 8.76            
Options remaining contractual term     8 years 7 months 6 days            
Option, unrecognized share-based compensation expense | $     $ 141,800            
Conversion of XPDI's Common Stock to New Core Common Stock                  
Class of Stock [Line Items]                  
Recapitalization transaction, conversion ratio         1        
Common Stock                  
Class of Stock [Line Items]                  
Issuances of common stock- Merger with XPDI (in shares) 30,800,000                
Stock options                  
Class of Stock [Line Items]                  
Period for recognition     3 years 8 months 12 days            
Restricted Stock Units and Restricted Awards                  
Class of Stock [Line Items]                  
Nonvested RSAs and RSUs (in shares)     96,900,000            
RSUs and RSAs, unrecognized share-based compensation expense | $     $ 768,700            
Share-based payment arrangement, cost expected to be recognized | $     $ 34,400            
Period for recognition     3 years 3 months 18 days            
Share-based payment arrangement, cost not expected to be recognized | $     $ 734,300            
Restricted Stock Units (RSUs)                  
Class of Stock [Line Items]                  
Share-based compensation, number of shares authorized (in shares)     1,400,000            
Restricted stock units granted in period (in shares)     11,900,000            
Restricted stock units grant-date fair value (in dollars per share) | $ / shares     $ 9.54            
2018 Plan                  
Class of Stock [Line Items]                  
Issuance period     10 years            
Share-based compensation, number of shares authorized (in shares)     132,000,000            
Common stock shares reserved for future issuance (in shares)     132,013,000            
2018 Plan | Stock options                  
Class of Stock [Line Items]                  
Common stock shares reserved for future issuance (in shares)     24,610,000            
2018 Plan | Minimum                  
Class of Stock [Line Items]                  
Share-based compensation, award vesting period     1 year            
2018 Plan | Maximum | Stock options                  
Class of Stock [Line Items]                  
Share-based compensation, award expiration period     10 years            
2021 Plan                  
Class of Stock [Line Items]                  
Share-based compensation, number of shares authorized (in shares)     45,000,000            
Common stock shares reserved for future issuance (in shares)     45,000,000            
2021 Plan | Stock options                  
Class of Stock [Line Items]                  
Share-based compensation, award expiration period     10 years            
Common stock shares reserved for future issuance (in shares)     0            
2021 Plan | Minimum                  
Class of Stock [Line Items]                  
Share-based compensation, award vesting period     1 year            
Blockcap Plans                  
Class of Stock [Line Items]                  
Common stock shares reserved for future issuance (in shares)     13,989,000       14,000,000    
Blockcap Plans | Stock options                  
Class of Stock [Line Items]                  
Common stock shares reserved for future issuance (in shares)     7,332,000            
Stockholder Loan Warrants                  
Class of Stock [Line Items]                  
Warrants outstanding (in shares)       200,000          
Exercise price of warrants (in dollars per share) | $ / shares               $ 4.21  
Public Warrants                  
Class of Stock [Line Items]                  
Warrants outstanding (in shares)     8,600,000            
Public Warrants | XPDI                  
Class of Stock [Line Items]                  
Warrants outstanding (in shares)         8,600,000        
Private Placement Warrants                  
Class of Stock [Line Items]                  
Warrants outstanding (in shares)     6,300,000            
Private Placement Warrants | XPDI                  
Class of Stock [Line Items]                  
Warrants outstanding (in shares)         6,300,000        
Executive Notes Warrants                  
Class of Stock [Line Items]                  
Warrants outstanding (in shares)                 6,400,000
Exercise price of warrants (in dollars per share) | $ / shares                 $ 0.84
Class of warrant or right, warrants exercised   3,200,000              
Issuance of common stock - exercise of warrants (in shares)   2,900,000              
Service Providers Warrants                  
Class of Stock [Line Items]                  
Warrants outstanding (in shares)                 200,000
Exercise price of warrants (in dollars per share) | $ / shares                 $ 4.27
Class of warrant or right, warrants exercised   200,000              
Issuance of common stock - exercise of warrants (in shares)   100,000